United States · 
Who invested in Tyrogenex?
Tyrogenex's investors include Brace Pharma.
2011201220132014
$970KSeed$3.3MDebt$15MSeries DUnited States · Series D startup
Who invested in Tyrogenex
Funding summaryUpdated 26 Oct 2026
$19Mraised across 3 rounds since 2011, from 3 sources
$970KSeed$3.3MDebt$15MSeries D
- Latest round
- Series D, $15MJun 2014
- Step-upi
- 4.6×
- Investors
- 1
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Seed, $970K Mar 2011
- Biggest round
- $15M Series D · Jun 2014
- Usual gap between rounds
- 3.1 years the median of 2
The rounds
- Jun 2014Series D$15M1 new
From a historical funding recordSEC filing: $8.2M sold, first sale Apr 2014
- Apr 2014Debt$3.3M
No investor was named in the report.
From a historical funding recordSEC filing: $3.3M sold, first sale May 2013
- Mar 2011
Founders and team
From the SEC filings it signed: 3 on the team.
- Chris LiangExecutive Officer, Directori
- Joseph StraightExecutive Officeri
- Michael WebbExecutive Officer, Directori
On the board, as filediAdam GoodfriendCheryl CalhounJohn IrwinSheridan SnyderTodd BradyVinzenz Ploerer
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Tyrogenex
How much has Tyrogenex raised?
Tyrogenex has raised $19M across 3 rounds since 2011.
When did Tyrogenex last raise?
Tyrogenex's most recent round was a Series D of $15M in Jun 2014.
What was Tyrogenex's biggest round?
Its most recent round, $15M in Jun 2014, is also its largest on record.
Who backed Tyrogenex first?
Tyrogenex's first round on record, in Jun 2014, was backed by Brace Pharma.
What stage is Tyrogenex at?
Tyrogenex's latest named round is a Series D, in Jun 2014.
Where is Tyrogenex based?
Tyrogenex is based in the United States.
Companies like Tyrogenex
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.